Elranatamab
Pfizer
['multiplemyeloma', 'pfizer']
we re at #asco23 sharing new data from our robust magnetismm program evaluating our investigational bispecific antibody in #multiplemyeloma. learn more: 
News and information for healthcare professionals about Pfizer’s presence at scientific congresses. Please read: https://t.co/xwMAFDI5j5